Literature DB >> 26232371

Parsimonious Description of Glucose Variability in Type 2 Diabetes by Sparse Principal Component Analysis.

Chiara Fabris1, Andrea Facchinetti1, Giuseppe Fico2, Francesco Sambo1, Maria Teresa Arredondo2, Claudio Cobelli3.   

Abstract

BACKGROUND: Abnormal glucose variability (GV) is a risk factor for diabetes complications, and tens of indices for its quantification from continuous glucose monitoring (CGM) time series have been proposed. However, the information carried by these indices is redundant, and a parsimonious description of GV can be obtained through sparse principal component analysis (SPCA). We have recently shown that a set of 10 metrics selected by SPCA is able to describe more than 60% of the variance of 25 GV indicators in type 1 diabetes (T1D). Here, we want to extend the application of SPCA to type 2 diabetes (T2D).
METHODS: A data set of CGM time series collected in 13 T2D subjects was considered. The 25 GV indices considered for T1D were evaluated. SPCA was used to select a subset of indices able to describe the majority of the original variance.
RESULTS: A subset of 10 indicators was selected and allowed to describe 83% of the variance of the original pool of 25 indices. Four metrics sufficient to describe 67% of the original variance turned out to be shared by the parsimonious sets of indices in T1D and T2D.
CONCLUSIONS: Starting from a pool of 25 indices assessed from CGM time series in T2D subjects, reduced subsets of metrics virtually providing the same information content can be determined by SPCA. The fact that these indices also appear in the parsimonious description of GV in T1D may indicate that they could be particularly informative of GV in diabetes, regardless of the specific type of disease.
© 2015 Diabetes Technology Society.

Entities:  

Keywords:  continuous glucose monitoring; glucose variability; type 1 diabetes; type 2 diabetes

Mesh:

Substances:

Year:  2015        PMID: 26232371      PMCID: PMC4738208          DOI: 10.1177/1932296815596173

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  25 in total

1.  A consensus perceived glycemic variability metric.

Authors:  Cynthia R Marling; Nigel W Struble; Razvan C Bunescu; Jay H Shubrook; Frank L Schwartz
Journal:  J Diabetes Sci Technol       Date:  2013-07-01

2.  Glucose variability indices in type 1 diabetes: parsimonious set of indices revealed by sparse principal component analysis.

Authors:  Chiara Fabris; Andrea Facchinetti; Giovanni Sparacino; Mattia Zanon; Stefania Guerra; Alberto Maran; Claudio Cobelli
Journal:  Diabetes Technol Ther       Date:  2014-06-23       Impact factor: 6.118

3.  Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control.

Authors:  Jan Šoupal; Jan Škrha; Martin Fajmon; Eva Horová; Miloš Mráz; Jan Škrha; Martin Prázný
Journal:  Diabetes Technol Ther       Date:  2014-01-08       Impact factor: 6.118

4.  Glycemic variability: measurement and utility in clinical medicine and research--one viewpoint.

Authors:  David Rodbard
Journal:  Diabetes Technol Ther       Date:  2011-08-04       Impact factor: 6.118

5.  Symmetrization of the blood glucose measurement scale and its applications.

Authors:  B P Kovatchev; D J Cox; L A Gonder-Frederick; W Clarke
Journal:  Diabetes Care       Date:  1997-11       Impact factor: 19.112

6.  Mean amplitude of glycemic excursions, a measure of diabetic instability.

Authors:  F J Service; G D Molnar; J W Rosevear; E Ackerman; L C Gatewood; W F Taylor
Journal:  Diabetes       Date:  1970-09       Impact factor: 9.461

7.  "J"-index. A new proposition of the assessment of current glucose control in diabetic patients.

Authors:  J M Wójcicki
Journal:  Horm Metab Res       Date:  1995-01       Impact factor: 2.936

8.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

9.  Characteristics of glycemic stability.

Authors:  F J Service; R L Nelson
Journal:  Diabetes Care       Date:  1980 Jan-Feb       Impact factor: 19.112

10.  Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.

Authors:  Edmond A Ryan; Tami Shandro; Kristy Green; Breay W Paty; Peter A Senior; David Bigam; A M James Shapiro; Marie-Christine Vantyghem
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

View more
  13 in total

1.  Simple Linear Support Vector Machine Classifier Can Distinguish Impaired Glucose Tolerance Versus Type 2 Diabetes Using a Reduced Set of CGM-Based Glycemic Variability Indices.

Authors:  Enrico Longato; Giada Acciaroli; Andrea Facchinetti; Alberto Maran; Giovanni Sparacino
Journal:  J Diabetes Sci Technol       Date:  2019-03-31

2.  Assessment of Glucose Control Metrics by Discriminant Ratio.

Authors:  Vanessa Moscardó; Pau Herrero; Monika Reddy; Nathan R Hill; Pantelis Georgiou; Nick Oliver
Journal:  Diabetes Technol Ther       Date:  2020-10       Impact factor: 6.118

3.  Diabetes and Prediabetes Classification Using Glycemic Variability Indices From Continuous Glucose Monitoring Data.

Authors:  Giada Acciaroli; Giovanni Sparacino; Liisa Hakaste; Andrea Facchinetti; Giorgio Maria Di Nunzio; Alessandro Palombit; Tiinamaija Tuomi; Rafael Gabriel; Jaime Aranda; Saturio Vega; Claudio Cobelli
Journal:  J Diabetes Sci Technol       Date:  2017-06-01

4.  Investigation of glucose fluctuations by approaches of multi-scale analysis.

Authors:  Yunyun Lai; Zhengbo Zhang; Peiyao Li; Xiaoli Liu; YiXin Liu; Yi Xin; Weijun Gu
Journal:  Med Biol Eng Comput       Date:  2017-08-21       Impact factor: 2.602

5.  Mean Levels and Variability in Affect, Diabetes Self-Care Behaviors, and Continuously Monitored Glucose: A Daily Study of Latinos With Type 2 Diabetes.

Authors:  Julie Wagner; Stephen Armeli; Howard Tennen; Angela Bermudez-Millan; Howard Wolpert; Rafael Pérez-Escamilla
Journal:  Psychosom Med       Date:  2017-09       Impact factor: 4.312

6.  A daily study of stressors, continuously measured glucose, and diabetes symptoms in latinos with type 2 diabetes.

Authors:  Julie Wagner; Stephen Armeli; Howard Tennen; Angela Bermudez-Millan; Howard Wolpert; Rafael Pérez-Escamilla
Journal:  J Behav Med       Date:  2020-06-03

7.  Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values.

Authors:  Feng-Fei Li; Bing-Li Liu; Reng-Na Yan; Hong-Hong Zhu; Pei-Hua Zhou; Hui-Qin Li; Xiao-Fei Su; Jin-Dan Wu; Dan-Feng Zhang; Lei Ye; Jian-Hua Ma
Journal:  Sci Rep       Date:  2017-05-08       Impact factor: 4.379

8.  Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy.

Authors:  Feng-Fei Li; Wen-Li Zhang; Bing-Li Liu; Dan-Feng Zhang; Wei Chen; Li Yuan; Mao-Yuan Chen; Xiao-Fang Zhai; Jin-Dan Wu; Xiao-Fei Su; Lei Ye; Hong-Yong Cao; Jian-Hua Ma
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

9.  Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes.

Authors:  Feng-Fei Li; Yun Shen; Rui Sun; Dan-Feng Zhang; Xing Jin; Xiao-Fang Zhai; Mao-Yuan Chen; Xiao-Fei Su; Jin-Dan Wu; Lei Ye; Jian-Hua Ma
Journal:  Diabetes Ther       Date:  2017-09-18       Impact factor: 2.945

10.  Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes.

Authors:  Feng-Fei Li; Bing-Li Liu; Guo-Ping Yin; Reng-Na Yan; Dan-Feng Zhang; Jin-Dan Wu; Lei Ye; Xiao-Fei Su; Jian-Hua Ma
Journal:  Sci Rep       Date:  2018-06-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.